Taurolidine-D6

CAS: 19388-87-5

Ref. TR-T009052

Produktinformation

• Name: Taurolidine-D6
• Synonyme: 4,4'-Methylenebis[tetrahydro-2H-1,2,4-thiadiazine 1,1,1',1'-Tetraoxide-D6, ‡4,4'-Methylenebis(perhydro-1,2,4-thiadiazin 1,1-dioxide)-D6, Taurolin-D6, Tauroline-D6, 2H-1,2,4-Thiadiazine, 4,4′-methylenebis[tetrahydro-, 1,1,1′,1′-tetraoxide, 4,4'-Methanediylbis(1,2,4-Thiadiazinane) 1,1,1',1'-Tetraoxide, 4,4'-Methylenebis(1,2,4-thiadiazinane) 1,1,1',1'-tetraoxide, 4,4'-Methylenebis(perhydro-1,2,4-thiadiazine 1,1-dioxide), 4,4'-Methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1',1'-tetraoxide, 4,4′-Methylenebis(perhydro-1,2,4-thiadiazin 1,1-dioxide), Bis(1,1-dioxoperhydro-1,2,4-thiadiazin-4-yl)methane, T 7329, Taurolin, Tauroline

Beschreibung

Stability Unstable in Aqueous Solution
Applications Taurolidine-D6 is a labelled analogue of Taurolidine (T009050). Taurolidine is a derivative of the amino acid Taurine (T007850). Taurolidine exhibits antiendotoxin and antimicrobial activity, and has also been shown to exhibit antitumour activity in vitro and in vivo. Taurolidine is used for the treatment of sepsis and is utilized in hospitals to prevent catheter-related bloodstream infections.
References Jurewitsch, B., et al.: J. Parent. Enter. Nut., 22, 242 (1998); McCourt, M., et al.: Ann. Surg. Oncol., 7, 685 (2000); Willatts, S., et al.: Crit. Care Med., 23, 1033 (1995)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 290.393
• Formel: C₇D₆H₁₀N₄O₄S₂
• Farbe/Form: Neat
• InChl: InChI=1S/C7H16N4O4S2/c12-16(13)3-1-10(5-8-16)7-11-2-4-17(14,15)9-6-11/h8-9H,1-7H2/i5D2,6D2,7D2
• InChI Key: InChIKey=AJKIRUJIDFJUKJ-IPSWUHLQSA-N
• SMILES: [2H]C1([2H])NS(=O)(=O)CCN1C([2H])([2H])N1CCS(=O)(=O)NC1([2H])[2H]